| UniProt ID | WIPI2_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y4P8 | |
| Protein Name | WD repeat domain phosphoinositide-interacting protein 2 | |
| Gene Name | WIPI2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 454 | |
| Subcellular Localization |
Preautophagosomal structure membrane Peripheral membrane protein Cytoplasmic side . Localizes to omegasomes membranes which are endoplasmic reticulum connected strutures at the origin of preautophagosomal structures. Enriched at preautophagosomal |
|
| Protein Description | Early component of the autophagy machinery being involved in formation of preautophagosomal structures and their maturation into mature phagosomes in response to phosphatidylinositol 3-phosphate (PtdIns3P). May bind PtdIns3P.; Isoform 4: Recruits the ATG12-ATG5-ATG16L1 complex to omegasomes and preautophagosomal structures, resulting in ATG8 family proteins lipidation and starvation-induced autophagy. Isoform 4 is also required for autophagic clearance of pathogenic bacteria. Isoform 4 binds the membrane surrounding Salmonella and recruits the ATG12-5-16L1 complex, initiating LC3 conjugation, autophagosomal membrane formation, and engulfment of Salmonella.. | |
| Protein Sequence | MNLASQSGEAGAGQLLFANFNQDNTEVKGASRAAGLGRRAVVWSLAVGSKSGYKFFSLSSVDKLEQIYECTDTEDVCIVERLFSSSLVAIVSLKAPRKLKVCHFKKGTEICNYSYSNTILAVKLNRQRLIVCLEESLYIHNIRDMKVLHTIRETPPNPAGLCALSINNDNCYLAYPGSATIGEVQVFDTINLRAANMIPAHDSPLAALAFDASGTKLATASEKGTVIRVFSIPEGQKLFEFRRGVKRCVSICSLAFSMDGMFLSASSNTETVHIFKLETVKEKPPEEPTTWTGYFGKVLMASTSYLPSQVTEMFNQGRAFATVRLPFCGHKNICSLATIQKIPRLLVGAADGYLYMYNLDPQEGGECALMKQHRLDGSLETTNEILDSASHDCPLVTQTYGAAAGKGTYVPSSPTRLAYTDDLGAVGGACLEDEASALRLDEDSEHPPMILRTD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 21 (in isoform 5) | Phosphorylation | - | 48.37 | 24275569 | |
| 24 (in isoform 5) | Phosphorylation | - | 28.51 | 24275569 | |
| 27 (in isoform 5) | Phosphorylation | - | 6.97 | 24275569 | |
| 28 | Ubiquitination | NQDNTEVKGASRAAG CCCCCCCCCHHHHCC | 42.39 | - | |
| 29 (in isoform 5) | Phosphorylation | - | 33.68 | 24275569 | |
| 35 (in isoform 5) | Phosphorylation | - | 27.90 | 24275569 | |
| 115 | Phosphorylation | TEICNYSYSNTILAV CEECCCCCCCEEEEE | 8.79 | 25332170 | |
| 118 | Phosphorylation | CNYSYSNTILAVKLN CCCCCCCEEEEEEEC | 16.07 | 25332170 | |
| 146 | Ubiquitination | IHNIRDMKVLHTIRE EEECCCCEEEEEECC | 46.03 | - | |
| 157 (in isoform 3) | Ubiquitination | - | 40.01 | 21906983 | |
| 164 (in isoform 3) | Ubiquitination | - | 5.29 | 21906983 | |
| 178 (in isoform 3) | Ubiquitination | - | 20.10 | 21906983 | |
| 198 (in isoform 4) | Ubiquitination | - | 2.46 | 21906983 | |
| 198 (in isoform 2) | Ubiquitination | - | 2.46 | 21906983 | |
| 205 (in isoform 2) | Ubiquitination | - | 5.15 | 21906983 | |
| 205 (in isoform 4) | Ubiquitination | - | 5.15 | 21906983 | |
| 211 (in isoform 5) | Ubiquitination | - | 33.93 | 21906983 | |
| 216 | Ubiquitination | AFDASGTKLATASEK EECCCCCEEEEECCC | 39.38 | 21906983 | |
| 216 (in isoform 1) | Ubiquitination | - | 39.38 | 21906983 | |
| 218 (in isoform 5) | Ubiquitination | - | 11.59 | 21906983 | |
| 219 (in isoform 2) | Ubiquitination | - | 40.95 | 21906983 | |
| 219 (in isoform 4) | Ubiquitination | - | 40.95 | 21906983 | |
| 223 (in isoform 1) | Ubiquitination | - | 58.34 | 21906983 | |
| 223 | Malonylation | KLATASEKGTVIRVF EEEEECCCCCEEEEE | 58.34 | 26320211 | |
| 223 | Ubiquitination | KLATASEKGTVIRVF EEEEECCCCCEEEEE | 58.34 | - | |
| 223 | Acetylation | KLATASEKGTVIRVF EEEEECCCCCEEEEE | 58.34 | 23749302 | |
| 232 (in isoform 5) | Ubiquitination | - | 2.15 | 21906983 | |
| 237 | Ubiquitination | FSIPEGQKLFEFRRG EECCCCHHHHHHHHH | 67.03 | 2190698 | |
| 237 (in isoform 1) | Ubiquitination | - | 67.03 | 21906983 | |
| 283 | Ubiquitination | KLETVKEKPPEEPTT EEEECCCCCCCCCCC | 61.22 | - | |
| 292 | Phosphorylation | PEEPTTWTGYFGKVL CCCCCCCCCCCCCHH | 21.66 | 25690035 | |
| 294 | Phosphorylation | EPTTWTGYFGKVLMA CCCCCCCCCCCHHHH | 11.20 | 25690035 | |
| 302 | Phosphorylation | FGKVLMASTSYLPSQ CCCHHHHCCCCCCHH | 12.15 | 27251275 | |
| 303 | Phosphorylation | GKVLMASTSYLPSQV CCHHHHCCCCCCHHH | 16.32 | 27251275 | |
| 304 | Phosphorylation | KVLMASTSYLPSQVT CHHHHCCCCCCHHHH | 23.37 | 27251275 | |
| 305 | Phosphorylation | VLMASTSYLPSQVTE HHHHCCCCCCHHHHH | 23.79 | 28555341 | |
| 308 | Phosphorylation | ASTSYLPSQVTEMFN HCCCCCCHHHHHHHH | 34.39 | - | |
| 322 (in isoform 3) | Phosphorylation | - | 10.33 | 22210691 | |
| 329 (in isoform 3) | Phosphorylation | - | 34.87 | 22210691 | |
| 331 | Ubiquitination | RLPFCGHKNICSLAT ECCCCCCCCCCCHHH | 33.04 | - | |
| 331 | Acetylation | RLPFCGHKNICSLAT ECCCCCCCCCCCHHH | 33.04 | 26051181 | |
| 331 (in isoform 3) | Phosphorylation | - | 33.04 | 22210691 | |
| 341 | Ubiquitination | CSLATIQKIPRLLVG CCHHHHHHCCHHHHC | 51.32 | - | |
| 363 (in isoform 2) | Phosphorylation | - | 74.65 | 22210691 | |
| 370 (in isoform 2) | Phosphorylation | - | 1.77 | 22210691 | |
| 371 | Ubiquitination | GGECALMKQHRLDGS CCEEEEEEEEECCCC | 43.75 | - | |
| 372 (in isoform 2) | Phosphorylation | - | 16.99 | 22210691 | |
| 376 (in isoform 5) | Phosphorylation | - | 44.59 | 22210691 | |
| 378 | Phosphorylation | KQHRLDGSLETTNEI EEEECCCCCCCHHHH | 23.77 | 27966365 | |
| 381 (in isoform 6) | Phosphorylation | - | 39.97 | 22210691 | |
| 381 | Phosphorylation | RLDGSLETTNEILDS ECCCCCCCHHHHHHH | 39.97 | 27251275 | |
| 382 | Phosphorylation | LDGSLETTNEILDSA CCCCCCCHHHHHHHH | 22.83 | 27251275 | |
| 383 (in isoform 5) | Phosphorylation | - | 41.55 | 22210691 | |
| 385 (in isoform 5) | Phosphorylation | - | 5.85 | 22210691 | |
| 388 (in isoform 6) | Phosphorylation | - | 28.38 | 22210691 | |
| 388 | Phosphorylation | TTNEILDSASHDCPL CHHHHHHHHCCCCCE | 28.38 | 25849741 | |
| 390 (in isoform 6) | Phosphorylation | - | 24.66 | 22210691 | |
| 390 | Phosphorylation | NEILDSASHDCPLVT HHHHHHHCCCCCEEE | 24.66 | 29978859 | |
| 397 | Phosphorylation | SHDCPLVTQTYGAAA CCCCCEEEEECCCCC | 23.91 | 19664994 | |
| 397 | O-linked_Glycosylation | SHDCPLVTQTYGAAA CCCCCEEEEECCCCC | 23.91 | OGP | |
| 399 | Phosphorylation | DCPLVTQTYGAAAGK CCCEEEEECCCCCCC | 17.98 | 26074081 | |
| 400 | Phosphorylation | CPLVTQTYGAAAGKG CCEEEEECCCCCCCC | 8.58 | 29978859 | |
| 408 | Phosphorylation | GAAAGKGTYVPSSPT CCCCCCCEECCCCCC | 25.49 | 23927012 | |
| 409 | Phosphorylation | AAAGKGTYVPSSPTR CCCCCCEECCCCCCE | 21.02 | 23927012 | |
| 412 | Phosphorylation | GKGTYVPSSPTRLAY CCCEECCCCCCEEEE | 38.62 | 23927012 | |
| 413 | Phosphorylation | KGTYVPSSPTRLAYT CCEECCCCCCEEEEE | 24.99 | 19664994 | |
| 415 | Phosphorylation | TYVPSSPTRLAYTDD EECCCCCCEEEEECC | 40.02 | 19664994 | |
| 419 | Phosphorylation | SSPTRLAYTDDLGAV CCCCEEEEECCCCCC | 18.46 | 26074081 | |
| 420 | Phosphorylation | SPTRLAYTDDLGAVG CCCEEEEECCCCCCC | 19.89 | 26074081 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| - | K | Ubiquitination | E3 ubiquitin ligase | HUWE1 | Q7Z6Z7 | PMID:30646805 |
| - | K | Ubiquitination | E3 ubiquitin ligase | CRL4A | - | PMID:30898011 |
| - | K | Ubiquitination | E3 ubiquitin ligase | CRLB | - | PMID:30898011 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of WIPI2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of WIPI2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-413, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-413, AND MASSSPECTROMETRY. | |